Mostrar el registro sencillo del ítem

dc.contributor.authorEsteban Gil, Angel
dc.contributor.authorPérez Sanz, Fernando
dc.contributor.authorGarcía Solano, José
dc.contributor.authorAlburquerque González, Begoña
dc.contributor.authorParreño González, María Antonia
dc.contributor.authorLegaz García, Maria del Carmen
dc.contributor.authorFernández Breis, Jesualdo Tomás
dc.contributor.authorRodríguez Braun, Edith
dc.contributor.authorPimentel, Paola
dc.contributor.authorMäkinen, Markus J.
dc.contributor.authorSlaby, Ondrej
dc.contributor.authorConesa Zamora, Pablo
dc.date.accessioned2026-02-26T14:56:26Z
dc.date.available2026-02-26T14:56:26Z
dc.date.issued2019-10-31
dc.identifier.citationEsteban-Gil, A., Pérez-Sanz, F., García-Solano, J. et al. ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer. Sci Data 6, 255 (2019). https://doi.org/10.1038/s41597-019-0198-zes
dc.identifier.isbn2052-4463
dc.identifier.urihttp://hdl.handle.net/10952/10867
dc.descriptionSe puede acceder al texto completo en la url de la revista : https://www.nature.com/articles/s41597-019-0198-z#citeases
dc.description.abstractColorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbiota and altered microRNA expression in CRC carcinogenesis, but their relationship with pathological drivers or molecular phenotypes is not clearly established. Joint analysis of clinical and omics data can help clarify such relations. We present ColPortal, a platform that integrates transcriptomic, microtranscriptomic, methylomic and microbiota data of patients with colorectal cancer. ColPortal also includes detailed information of histological features and digital histological slides from the study cases, since histology is a morphological manifestation of a complex molecular change. The current cohort consists of Caucasian patients from Europe. For each patient, demographic information, location, histology, tumor staging, tissue prognostic factors, molecular biomarker status and clinical outcomes are integrated with omics data. ColPortal allows one to perform multiomics analyses for groups of patients selected by their clinical data.es
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal canceres
dc.typejournal articlees
dc.rights.accessRightsopen accesses
dc.journal.titleScientific dataes
dc.issue.number6es
dc.description.disciplineMedicinaes
dc.identifier.doi10.1038/s41597-019-0198-zes
dc.description.facultyMedicinaes


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional